For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20241018:nRSR6779Ia&default-theme=true
RNS Number : 6779I Iofina PLC 18 October 2024
18 October 2024
Iofina plc
("Iofina", the "Company" or the "Group")
(AIM: IOF)
Q3 2024 Update
Iofina plc, specialists in the exploration and production of iodine and
manufacturers of specialty chemical products, today provides a brief update to
the market regarding its activities during Q3 2024 (the "Period").
Iofina Resources produced 163.9 metric tonnes (MT) of crystalline iodide
during Q3 2024 (Q3 2023: 156.9 MT) from its six IOsorb® plants in western
Oklahoma. Our seventh operating plant, IO#10, began concentrating iodide
towards the end of the Period and is now producing crystalline iodine. As
total production ramps up in Q4 2024, as it stands, second-half production
remains on track to achieve within the forecast range of 355-380 MT.
Iodine demand remains high, with the average H2 2024 iodine sales prices for
crystalline iodine currently higher than the average in the first half of the
year (H1 2024: $66.84/kg 100% basis). This trend is expected to continue into
2025 as the demand for iodine is expected to exceed supply in the medium term.
The Company's plants continue to perform well. Iofina continues to work with
our partners regarding brine flow supply to each plant and has recently seen
supply increase at two of our plants late in the Period.
Looking ahead, the announcement of IO#11 in the Period with an existing
partner further demonstrates the Company's execution of its accelerated growth
strategy. IO#11 will commence construction in Q4 2024, and developments will
be disclosed as it progresses. Plans for further plants beyond IO#11 are
already underway and those discussions will be relayed to the market in due
course.
President and CEO, Dr. Tom Becker, stated:
"The Group has delivered an excellent performance in the Period, with major
milestones achieved. Not only did we commission IO#10, but by utilising a
strong relationship with one of our existing brine suppliers, we managed to
finalise an agreement for IO#11.
"We continue to execute our business plan of prudent but accelerated growth of
our iodine production. Additionally, our restructured and favourable loan
terms have enabled us the flexibility to achieve faster growth.
"We expect to meet the crystalline iodine production range of 355-380 MT for
H2 2024. The Company continues to experience strong sales, driven by sustained
demand and increasing iodine prices. We look forward to reporting on further
progress in our Q4 2024 update."
Enquiries:
Iofina plc
Dr. Tom Becker
CEO & President
Tel: +44 (0)20 3006 3135
Nomad & Broker:
Canaccord Genuity Limited
Henry Fitzgerald-O'Connor/Harry Rees
Tel: +44 (0)20 7523 8000
Financial PR and Media Contact:
Yellow Jersey PR Limited
Charles Goodwin/Shivantha Thambirajah/Zara McKinlay
Tel: +44 (0)7747 788 221/+44 (0)7983 521 488
About Iofina:
Iofina plc (AIM: IOF) is a vertically integrated company that specialises in
the production of Iodine and the manufacturing of specialty chemical products.
Iofina is the second largest producer of iodine in North America and operates
the manufacturing entities Iofina Resources and Iofina Chemical.
LEI: 213800QDMFYVRJYYTQ84
ISIN: GB00B2QL5C79
Iofina Resources
Iofina Resources develops, builds, owns, and operates iodine extraction plants
using Iofina's WET® IOsorb® technology. Iofina operates seven IOsorb®
plants in Oklahoma and consistently uses technology and innovation to improve
and expand its operations.
Iofina Chemical
Iofina Chemical has manufactured high quality halogen speciality chemicals
derived from raw iodine, as well as non-iodine-based products. Iofina
Chemical celebrated its 40(th) anniversary in 2023 as a preeminent
halogen-based specialty chemicals company.
www.iofina.com (http://www.iofina.com/)
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
or visit
www.rns.com (http://www.rns.com/)
.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
. END UPDDDLFFZBLXFBB